North America Pet Diabetes Care Market Size, Share & Industry Trends Analysis Report By Animal Type, By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce), By Solution, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Pet Diabetes Care Market
Market Report Description
The North America Pet Diabetes Care Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
Although a pet's symptoms may suggest diabetes, the veterinarian must uncover persistent hyperglycemia and glucosuria to make the diagnosis. Even though a diabetes diagnosis is frequently easy to make, the doctor may order further blood tests to rule out some other illnesses that are common in older pets. To check out a urinary tract infection, a urine culture may be advised. The veterinarian would recommend a dosage and kind of insulin for the pet once the diagnosis has been made. Insulin must be administered intravenously; it cannot be taken orally.
The administration of insulin injections that require the use of a very small needle and are typically very well accepted by the animal, would be demonstrated to pet owner by the veterinarian or a veterinary technician. That is not a one-size-fits-all treatment; depending on the findings of monitoring, the veterinarian might have to sometimes modify the pet's treatment plan. Dietary advice is a crucial component of treatment.
Diabetes in dogs and cats typically requires lifelong management, including specialized diets, regular exercise, and, more frequently in dogs, daily insulin injections. The secret to treating diabetic pets is to maintain their blood sugar levels close to normal and steer clear of dangerously high or low levels. As pet owner and their pet acclimate to the new diet and meds, patience is essential. A treatment that is effective for one pet may not be as effective for another pet.
In the area, there is an upsurge in the adoption of pets. For example, 68 percent of American homes, or about 85 million families, own a pet, according to the American Pet Products Association's (APPA) National Pet Owners Survey. Dogs and cats are thus the most prevalent pets in American households. As a result, the dramatic rise of pet adoption and owners' growing concern about their pets' health are significant drivers of the industry's expansion. Additionally, the region's market for pet diabetes care devices is anticipated to increase as a result of the presence of major industry participants in the area and the rising incidence of diabetes.
The US market dominated the North America Pet Diabetes Care Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $634.5 million by 2028. The Canada market is poised to grow at a CAGR of 9.5% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.5% during (2022 - 2028).
Based on Animal Type, the market is segmented into Dogs and Cat. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce. Based on Solution, the market is segmented into Treatment (Insulin Therapy, Insulin Delivery Devices, and Others) and Glucose Monitoring Devices. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Merck & Co., Inc., Zoetis, Inc., ACON Laboratories, Inc., Allison Medical, Inc., i-SENS, Inc., Trividia Health, Inc., UltiMed, Inc., and Taidoc Technology Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Animal Type
By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Insulin Therapy
- Insulin Delivery Devices
- Glucose Monitoring Devices
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- Becton, Dickinson and Company
- Merck & Co., Inc.
- Zoetis, Inc.
- ACON Laboratories, Inc.
- Allison Medical, Inc.
- i-SENS, Inc.
- Trividia Health, Inc.
- UltiMed, Inc.
- Taidoc Technology Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free